Wendi Schultz

Wendi Schultz is a Director of Early-Stage Development and a Scientific Communications Leader with extensive experience in the biotechnology industry, particularly in oncology. They currently work at Pfizer, where they focus on strategic scientific communications. Wendi previously contributed to Seagen in Medical Affairs, managing scientific communication activities and publication planning. They hold a Master's degree in Pharmacology and Toxicology from MSU and a B.S. in Zoology from Washington State University, along with credentials as a Certified Medical Publication Professional.